Loss of FASN is sufficient to delay tumor initiation, and this is largely correlated with increased sterol regulatory element-binding proteins (SREBPs) activity, which results in the upregulation of genes involved in DNL and cholesterol biosynthesis [32]. The gene discussed is FASN; the disease is neoplasm.